Finally, we show that 2DG, especially at low, physiologically achievable concentrations that do not substantially inhibit glycolysis, was able to reduce the PD-1/CD69 ratio and stimulate IFN-γ secretion while mostly preserving IL-2 secretion in Jurkat cells, suggesting potential utility in boosting anti-cancer immunity. The gene discussed is CD69; the disease is cancer.